Sunday, August 03, 2025 11:36:02 AM
In this world we live in, it's sometimes hard to understand one's motives.
Some seem more driven to tear down innovation than to support progress — especially when that innovation threatens to shift the landscape in a meaningful way.
The relentless negativity we see from a few voices isn’t rooted in logic or science — it's rooted in fear. Fear that this actually might work. That RadioGel could truly be disruptive. And that their narratives, tied to outdated thinking or other interests, may no longer hold weight in a world that’s ready for something better.
No one wastes time attacking something that doesn’t matter.
You don’t see trolls obsessing over failed concepts.
They circle the ones with potential.
They attack what they can’t control.
So while it may be frustrating, take it as a sign — we’re onto something real.
Let them talk. Let them doubt.
Meanwhile, science will move forward. And so will we.
$RDGL
Some seem more driven to tear down innovation than to support progress — especially when that innovation threatens to shift the landscape in a meaningful way.
The relentless negativity we see from a few voices isn’t rooted in logic or science — it's rooted in fear. Fear that this actually might work. That RadioGel could truly be disruptive. And that their narratives, tied to outdated thinking or other interests, may no longer hold weight in a world that’s ready for something better.
No one wastes time attacking something that doesn’t matter.
You don’t see trolls obsessing over failed concepts.
They circle the ones with potential.
They attack what they can’t control.
So while it may be frustrating, take it as a sign — we’re onto something real.
Let them talk. Let them doubt.
Meanwhile, science will move forward. And so will we.
$RDGL
Know what you own, and know why you own it.
Recent RDGL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 09:14:29 PM
